Activity

  • Eligah Cardenas posted an update 3 days, 21 hours ago

    Fiscella K, Winters P, Tancredi D, Hendren S, Franks P. Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? Cancer. 2011;117:1061?. 9. Mezawa H, Sugiura T, Watanabe M, Norizoe C, 1756285611405390 Takahashi D, Shimojima A, et al. Serum vitamin D levels and survival of patients with colorectal journal.pone.0023913 cancer: post-hoc analysis of a prospective cohort study. BMC Cancer. 2010;ten:347. 10. Moan J, Porojnicu AC, Robsahm TE, Dahlback A, Juzeniene A, Tretli S, et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B. 2005;78:189?3.Vashi et al. BMC Cancer (2015) 15:Web page 9 of11. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, et al. Circulating 25-hydroxyvitamin d levels and survival in individuals with colorectal cancer. J Clin Oncol. 2008;26:2984?1. 12. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009;27:3757?three. 13. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res. 2011;13:R74. 14. Tretli S, Hernes E, Berg JP, Hestvik UE, Robsahm TE. Association involving serum 25(OH)D and death from prostate cancer. Br J Cancer. 2009;one hundred:450?. 15. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, et al. Prediagnostic plasma vitamin D metabolites and mortality amongst sufferers with prostate cancer. PLoS One. 2011;6:e18625. 16. Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL. Circulating levels of 25hydroxyvitamin D and prostate cancer prognosis. Cancer Epidemiol. 2013;37:666?0. 17. Gupta D, Trukova K, Popiel B, Lammersfeld C, Vashi PG. The Association involving Pre-treatment Serum 25-hydroxyvitamin D and Survival in Newly Diagnosed Stage IV Prostate Cancer. PLoS A single 2015;ten(3):e0119690. 18. Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007;25:479?five. 19. Tretli S, cb200100f Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25hydroxyvitamin D and survival in Norwegian sufferers with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Manage. 2012;23:363?0. 20. Cheng TY, Neuhouser ML. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality inside the US population: a prospective nutrient-nutrient interaction. Cancer Causes Control. 2012;23:1557?five. 21. Heist RS, Zhou W, Wang Z, Liu G, Neuberg D, Su L, et al. Circulating 25hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-smallcell lung cancer. J Clin Oncol. 2008;26:5596?02. 22. Turner AM, McGowan L, Millen A, Rajesh P, Safflower YellowMedChemExpress Safflower Yellow Webster C, Langman G, et al. Circulating DBP level and prognosis in operated lung cancer: an exploration of pathophysiology. Eur Respir J. 2013;41:410?. 23. Anic GM, Weinstein SJ, Mondul AM, Mannisto S, Albanes D. Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer. 2014;86:297?03.